INTERLEUKIN 2

INTERLEUKIN 2 Struktur
268535-76-8
CAS-Nr.
268535-76-8
Englisch Name:
INTERLEUKIN 2
Synonyma:
INTERLEUKIN 2;GenBank CAB65230;Interleukin 2 (turkey gene il2);GenBank CAB65230 (Translated from: GenBank AJ007463);Interleukin 2 (Meleagris gallopavo splenocyte gene il2);Interleukin 2 (Meleagris gallopavo gene IL-2 precursor)
CBNumber:
CB1636385
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

INTERLEUKIN 2 Eigenschaften

storage temp. 
-20°C
CAS Datenbank
268535-76-8

Sicherheit

INTERLEUKIN 2 Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Cetus has introduced a stable rDNA interleukin-2 (rIL-2) for the treatment of renal cell carcinoma. Recent studies showed that rIL-2 in combination with lymphokine activated killer cells or tumor infiltrating lymphocytes induced regression or partial regression in patients with advanced metastatic cancers.

Definition

A type of biological response modifier (a substance that can improve the body’s natural response to disease). It stimulates the growth of certain disease-fighting blood cells in the immune system. Also called IL-2.

Indications

IL-2 (Proleukin) is a cytokine that promotes the proliferation, differentiation, and recruitment of T and B lymphocytes, natural killer cells, and thymocytes. Human recombinant IL-2 is designated as rIL-2. rIL-2 binds to IL-2 receptors on responsive cells and induces proliferation and differentiation of T helper cells and T cytotoxic cells. It also can induce B-lymphocyte proliferation, activate macrophage activity, and augment the cytotoxicity of natural killer cells.

Mechanism of action

rIL-2 is administered systemically as an immunostimulating agent in patients with AIDS and to augment specific antitumor immunity. Patients with renal cell carcinoma or melanoma have been effectively treated with rIL-2 in combination with adoptive transfer immunotherapy. The latter refers to the injection of the patient’s own cytokine-activated killer cells or tumorinfiltrating lymphocytes after they reside in tissue culture for several weeks in the presence of rIL-2.

Clinical Use

Protein of rDNA origin that is used in treating renal cell carcinoma and metastatic malignant melanoma.

Nebenwirkungen

Systemic administration of rIL-2 causes fever, nausea, vomiting, fatigue, and malaise. Other adverse affects include flushing, diarrhea, chills, rash, edema, symptomatic hypotension, and certain renal abnormalities. These tend to occur at increased dosage levels and are attenuated by reducing the dosage.

INTERLEUKIN 2 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


INTERLEUKIN 2 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 12)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Sigma-Aldrich 021-61415566 800-8193336
orderCN@merckgroup.com China 51471 80
Chengdu Youngshe Chemical Co., Ltd. +86-17380623303 +86-17380623303
Caroline@youngshechem.com China 2359 58

  • INTERLEUKIN 2
  • Interleukin 2 (Meleagris gallopavo gene IL-2 precursor)
  • Interleukin 2 (Meleagris gallopavo splenocyte gene il2)
  • Interleukin 2 (turkey gene il2)
  • GenBank CAB65230
  • GenBank CAB65230 (Translated from: GenBank AJ007463)
  • 268535-76-8
Copyright 2019 © ChemicalBook. All rights reserved